#ESG trends in pharmaceutical industry

[esglatestmarketnews]

ESG Reporting and Transparency in the Pharmaceutical Manufacturing Sector

Pharmaceutical manufacturing has repeatedly stepped up during global crises, including the COVID-19 pandemic and the Russia-Ukraine conflict. Industry leaders are recognizing the significance of environmental, social and governance (ESG) pillars, including climate change, diversity, equity & inclusion (DEI), product innovation, business ethics, equitable access & pricing and product quality. The need to embed and align responsible business practices for strategic decisions, governance and business operations will augur well for purpose-driven pharmaceutical manufacturing organizations.

Leading companies are exploring the United Nations Sustainable Development Goals (UN SDGs) and Global Reporting Initiative to help pharmaceutical players assess their impacts on corruption, climate change and human rights and pursue opportunities to solve societal challenges.

The global push to develop and build a resilient, equitable and sustainable health system has encouraged stakeholders to achieve a safe, ethical and responsible culture by harnessing the power of innovation and science.

Surmounting Climate Change Concerns—Environmental Pillar

Pharma companies are navigating the environmental challenges that have become notorious for causing a surge in health inequalities, chronic diseases and the burden on the health system.  The environmental impact of drug manufacturing can lead to carbon emissions, pollution and water depletion. Accordingly, access to healthcare and environmental sustainability has come to the fore as an invaluable proposition.

Stakeholders are expected to use emission control practices, technologies, and environmental risk assessment methodologies to limit the discharge of active pharmaceutical ingredients to wastewater from manufacturing processes. For instance, in 2021, Pfizer forged a virtual PPA with Vesper Energy (Vesper), wherein the latter will provide a minimum of 310 MW of renewable energy to the grid from the Hornet Solar project (in west Texas).

Is your business one of participants to the Pharmaceutical Manufacturing Industry? Contact us for focused consultation around ESG Investing, and help you build sustainable business practices

Emphasis on Expanding Healthcare Access—Social Pillar

The havoc wrecked by the COVID-19 pandemic proved to be a litmus test for healthcare workers, frontline employees and the public amidst soaring demand to bolster healthcare resilience, boost access to life-saving treatments and foster sustainable healthcare solutions. A buoyant ESG approach alludes to expanding geographies where rare disease medicines are available, ramping up patient access, addressing unmet medical needs and enhancing product life cycle management.

Data analytics can be instrumental for early diagnosis, medical research and training. In 2022, AstraZeneca joined forces with the EDISON Alliance of World Economic Forum to enhance the lives of 1 billion people by 2025 through digital inclusion. The pharmaceutical giant is committed to using AI-based technology to screen 5 million patients for lung cancer.

Ethics and Transparency Vital to Embed ESG Culture—Governance Pillar

Decision-making that complements ethics, quality, transparency and integrity serves as a precursor to governance goals. As the industry moves towards a sustainable future, sound corporate governance will be pivotal to underscore ESG performance. With the pharma industry investing in life-saving drugs, incumbent players are well-positioned to underpin their governance portfolio.

Robust ethical behavior speaks volumes of how industry leaders are doing the right thing—reporting and investigating concerns. For instance, 87% of employees at GlaxoSmithKline believe they “can and do speak up if things don’t feel right.” In 2022, the behemoth reportedly conducted 1,060 quality audits of its suppliers, emphasizing active pharmaceutical ingredient suppliers and propelling product governance.

Corporate governance warrants commitment to high ethical standards to underscore trust among stakeholders and underpin transparency and integrity. Sustainability-focused decision-making will help companies bolster their brand position through ethical decision-making, accountability, supply chain transparency, data privacy & protection and risk management. Notably, audit programs in manufacturing, clinical, preclinical and logistics will ensure that products are compliant with regulatory requirements. Bullish governance policies will muster up the confidence of investors, entrepreneurs, shareholders and other stakeholders.

Reaping Benefits of ESG—a Vital Cog for Business

The future of the pharma industry alludes to a sustainable approach to building a healthier planet. Investments in net zero buildings, renewables, patient engagement, reducing the environmental footprint of the supply chain and manufacturing and medicine optimization will engineer ESG growth. Stakeholders are pushing to the limits to create an atmosphere to impel DEI, provide decent work and economic growth, gender equality, minimize inequalities, foster corporate governance and communicate ESG goals to the public. Prevailing trends exhort the valuation of the global pharmaceutical manufacturing market size at USD 405.52 billion in 2020 and back the expected CAGR of 11.34% between 2021 and 2028.

About Astra – ESG Solutions By Grand View Research

Astra is the Environmental, Social, and Governance (ESG) arm of Grand View Research Inc. - a global market research publishing & management consulting firm.

Astra offers comprehensive ESG thematic assessment & scores across diverse impact & socially responsible investment topics, including both public and private companies along with intuitive dashboards. Our ESG solutions are powered by robust fundamental & alternative information. Astra specializes in consulting services that equip corporates and the investment community with the in-depth ESG research and actionable insight they need to support their bottom lines and their values. We have supported our clients across diverse ESG consulting projects & advisory services, including climate strategies & assessment, ESG benchmarking, stakeholder engagement programs, active ownership, developing ESG investment strategies, ESG data services, build corporate sustainability reports. Astra team includes a pool of industry experts and ESG enthusiasts who possess extensive end-end ESG research and consulting experience at a global level.

Need expert consultation around identifying, analyzing and creating a plan to mitigate ESG risks related to your business? Share your concerns and queries, we can help!

Read More ESG Blogs

[essarairsystems]

Global Pharmaceutical And Biotechnology Consulting Services Provider

Exploring the Role of Global Pharmaceutical and Biotechnology Consulting Services Providers

In the intricate world of pharmaceuticals and biotechnology, where innovation meets stringent regulatory requirements, the role of consulting services providers is indispensable. These firms serve as trusted advisors, guiding companies through the complex landscape of drug development, regulatory compliance, market access, and operational efficiency. Their expertise spans from small biotech startups to multinational pharmaceutical giants, offering tailored solutions to meet diverse needs across the globe.

Understanding the Need

The pharmaceutical and biotechnology industries are characterized by rapid advancements in science and technology, stringent regulatory frameworks, and evolving market dynamics. Navigating this terrain requires not only scientific excellence but also strategic foresight and regulatory acumen. Consulting services providers specialize in filling these knowledge gaps, offering insights and strategies that empower companies to make informed decisions and achieve their goals effectively.

Services Offered

Regulatory Affairs: Navigating the complex regulatory pathways is crucial for bringing new drugs and therapies to market. Consulting firms provide expertise in regulatory strategy, submissions, and compliance, ensuring that products meet global standards and timelines.

Clinical Development: From protocol design to clinical trial management, consultants offer strategic guidance to optimize trial outcomes while adhering to ethical and regulatory guidelines. This includes patient recruitment strategies, data management, and regulatory reporting.

Market Access: Understanding the market landscape and securing reimbursement are critical for commercial success. Consultants provide market access strategies, pricing and reimbursement support, and health economics assessments to maximize product uptake and profitability.

Quality Assurance and Compliance: Maintaining high standards of quality and compliance is non-negotiable in pharmaceuticals. Consultants offer support in quality management systems, audits, and remediation strategies to ensure adherence to global regulations.

Business Development and Strategy: Strategic planning is vital for growth and sustainability. Consulting firms assist with business development strategies, partnerships, mergers and acquisitions (M&A), and portfolio optimization to drive long-term success.

Global Reach and Impact

The reach of pharmaceutical and biotechnology consulting services extends across borders, serving companies worldwide. Whether navigating the FDA approval process in the United States, securing EMA approval in Europe, or navigating regulatory frameworks in emerging markets, these firms provide localized expertise with a global perspective.

Key Trends and Innovations

Digital Transformation: Leveraging technology such as artificial intelligence (AI) and data analytics to optimize clinical trials, improve patient outcomes, and enhance operational efficiency.

Personalized Medicine: Advancing towards precision medicine by tailoring treatments to individual genetic profiles, with consultants guiding companies through the complexities of biomarker identification and companion diagnostics.

Healthcare Sustainability: Promoting sustainability in drug development and manufacturing processes, aligning with environmental, social, and governance (ESG) principles.

Conclusion

In conclusion, global pharmaceutical and biotechnology consulting services providers play a pivotal role in advancing innovation, ensuring regulatory compliance, and driving commercial success in these highly regulated industries. Their multidisciplinary expertise, combined with a deep understanding of local and global markets, makes them invaluable partners for companies aiming to navigate the complexities of drug development and commercialization effectively.

As the landscape continues to evolve with technological advancements and regulatory changes, the role of these consulting firms will only become more critical in shaping the future of healthcare and biotechnology worldwide.

[shristisahu]

Title: "Pioneering Tomorrow's Pharma Supply Chains: Unveiling Supplier Intelligence"

Originally Published on: SpendEdge |Future of Supplier Intelligence in the Pharma Industry

Evolving Supplier Intelligence: Navigating New Frontiers

The pharmaceutical industry stands at the precipice of a transformative epoch, driven by data-driven insights and a renewed emphasis on adaptability and resilience. In this dynamic landscape, the role of supplier intelligence emerges as pivotal, necessitating a departure from traditional methodologies towards agile and dynamic approaches. This discourse delves into the future of supplier intelligence within the pharmaceutical domain, outlining key trends and navigating the challenges steering its trajectory.

Challenges with Conventional Approaches

Historically, supplier intelligence within pharmaceuticals leaned heavily on archival data, limiting foresight into forthcoming performance metrics and potential disruptions. The rigidity of traditional methods proved inadequate in adapting to the fluidity of market dynamics, leaving enterprises vulnerable to emerging risks.

Emerging Trends in Supplier Intelligence

The horizon of supplier intelligence in pharmaceuticals is marked by several salient trends:

Data-Driven Decision Making: A proliferation of data reservoirs empowers objective supplier assessments and prognostic insights.

Risk Management and Visibility: Real-time monitoring mechanisms, coupled with IoT sensors, bolster visibility, enabling preemptive risk mitigation.

Sustainability and Ethical Sourcing: An emphasis on Environmental, Social, and Governance (ESG) criteria embeds ethical sourcing practices into supplier selection frameworks.

Collaboration and Knowledge Exchange: Secure platforms for data exchange foster symbiotic relationships and perpetual enhancements.

AI and ML Integration: Advanced algorithms navigate vast data pools, prognosticating supplier trajectories and optimizing inventory oversight.

Advantages of Enhanced Supplier Intelligence

Embracing these progressive paradigms furnishes manifold advantages, encompassing streamlined operations, fortified risk mitigation, catalyzed innovation, and reinforced sustainability protocols.

Overcoming Implementation Hurdles

Confronting obstacles such as data amalgamation, cybersecurity fortification, and adept personnel acquisition emerges as essential for successful integration.

The Evolution of Pharma Supply Chains

Pharmaceutical supply chains must evolve to accommodate burgeoning supplier ecosystems, underscored by tenets of transparency, adaptability, accessibility, and synergy.

In Conclusion

The trajectory of supplier intelligence within the pharmaceutical domain is etched with data-driven dynamism, collaborative ethos, and a steadfast focus on risk aversion. Triumphing over implementation impediments and embracing emergent trends will equip enterprises to sculpt robust and sustainable supply chains, ensuring perpetual prosperity in an ever-evolving global milieu.

Contact us.

[philomathresearch]

Market Research 2024: Services and Solutions Reshaping Industries

Introduction:

In the dynamic landscape of business, staying ahead requires a keen understanding of market trends, consumer behavior, and industry shifts. As we step into 2024, the role of market research becomes increasingly crucial. In this blog post, we'll explore the services and solutions that are reshaping industries in the realm of market research.

I. Evolution of Market Research Services:

Big Data Integration:The advent of big data has transformed the market research landscape. Companies now harness vast amounts of data to derive actionable insights. Market research services are integrating big data analytics, providing a more comprehensive understanding of consumer preferences, market dynamics, and competitive landscapes.

Advanced Analytics and AI:Artificial Intelligence (AI) and advanced analytics are revolutionizing how market research is conducted. Machine learning algorithms analyze data at unprecedented speeds, allowing for real-time insights. Predictive analytics models enable businesses to anticipate market trends, helping them make informed decisions and stay ahead of the competition.

II. Key Market Research Solutions:

Mobile Research Platforms:The ubiquity of smartphones has given rise to mobile research platforms. These solutions enable researchers to gather data directly from consumers in real-time and in their natural environments. The convenience of mobile surveys and feedback mechanisms enhances the accuracy and relevance of data collected.

Virtual Reality (VR) in Consumer Studies:Market researchers are increasingly leveraging virtual reality to conduct immersive consumer studies. VR simulations offer a realistic environment for testing products and gauging consumer reactions. This technology provides a deeper understanding of consumer behavior and preferences, particularly in industries like gaming, retail, and real estate.

Blockchain for Data Security:With data breaches becoming more prevalent, ensuring the security and integrity of research data is paramount. Blockchain technology is emerging as a solution to enhance data security in market research. It provides a transparent and tamper-proof system, assuring stakeholders that the information collected is reliable and protected.

III. Industry-Specific Impacts:

Healthcare and Pharmaceutical:In the healthcare and pharmaceutical industries, market research plays a critical role in understanding patient needs, optimizing drug development, and identifying opportunities for innovation. Advanced analytics and AI-driven insights are expediting drug discovery processes, leading to more efficient and targeted healthcare solutions.

Technology and Innovation:Technology companies rely on market research to stay attuned to rapidly changing consumer preferences. VR and augmented reality studies, coupled with big data analytics, enable tech innovators to anticipate the demand for new products and improve existing ones.

E-commerce and Retail:The e-commerce and retail sectors are witnessing a shift towards personalized shopping experiences. Market research solutions, such as recommendation engines powered by AI, help businesses tailor their offerings to individual consumer preferences, ultimately enhancing customer satisfaction and loyalty.

IV. Challenges and Future Trends:

Privacy Concerns:As market research becomes more sophisticated, addressing privacy concerns is paramount. Companies need to navigate the delicate balance between collecting valuable data and respecting consumer privacy. Striking this balance will be crucial for the continued success of market research initiatives.

Emphasis on Sustainability:The future of market research will likely see a growing emphasis on sustainability. Companies will integrate environmental, social, and governance (ESG) factors into their research methodologies to align with the increasing focus on corporate responsibility and sustainable business practices.

Conclusion:

Market research in 2024 is not just a tool for understanding the present but a compass for navigating the future. The integration of advanced technologies, industry-specific solutions, and a commitment to ethical practices will continue to reshape how businesses approach market research. As we move forward, the evolving landscape promises exciting opportunities and challenges for both researchers and the industries they serve. Stay tuned to Philomath Research for more insights into the dynamic world of market research.

[legalfundservices]

Legal Expenses Market in India

The demand for legal services exists in times of adversity as well as growth, as is evident from the Covid-19 situation. Even before 2021, legal costs in India were rising with each passing year but dipped in FY 2021 which was still 12.42% higher than FY 2019. Market difficulties, regulatory responses, stimulus programmes, changes in employment, and other stressors provide potential sources of demand for legal services.

India has acquired a reputation of an expensive legal system. For perspective, India’s GDP in 1991 was $266 Billion and is expected to cross $5 Trillion by 2025. Such growth in the economy runs parallel to growing legal complexity. India’s booming unicorn landscape has been a catalyst for a higher than ever investor & founder disputes. Debt and equity financing, private equity, mergers and acquisitions and venture capitalists are some areas that are witnessing increased commercial cases and arbitrations. This spectacular economic growth will fuel the Indian market for legal expenses as well. According to the Legal Services Authorities Act, 1987 (Government of India), Legal Service includes the rendering of any service in the conduct of any case or other legal proceeding before any court or other authority or tribunal and the giving of advice on any legal matter.

In FY 2020, legal expenses rose 9% to 38754 crores. It has been observed that when the economy doubles, the legal expenses triple. They are forecasted to be over 1 lakh crore by 2025 and 3 lakh crores by 2030. Increased FDI and shifting tax regimes have also contributed to increasing legal costs. For instance, Amazon spent Rs 8,546 crore ($1.2 Billion) in legal expenses during 2018-2020 to maintain its presence in India. Around 20% of Amazon’s revenue was being spent on lawyer fees. The rise in demand for more sophisticated legal services was followed by rise in the supply as well. Despite that, the expenses kept soaring.

In FY2021, the pharmaceutical industry marked the highest legal spending at an aggregate of nearly Rs. 7595 crores while the telecom industry marked the highest spike in its legal expenses at a whopping 48.88% YoY change. The pharma sector was followed by Infotech, banks, finance and capital goods in terms of highest spenders. Out-of-court settlements are becoming more commonly practiced as companies try to save both time and money. The total legal spending of all the listed companies on Indian exchanges may sound big, but it is minuscule at just 0.47% of their total revenue and 0.59% of total expenditure. However, the recent trends suggest that this percentage is going to skyrocket later in this decade.

At a global level, In the last decade, the size of the market for legal services has nearly doubled where US companies spent 166% more on legal services than its counterparts. This is due to its complex corporate landscape and varying tax laws and other regulations in different states. Similarly, as India continues to adopt globalization, disputes with respect to finance, corporate restructuring, and governance such as ESG and intellectual property rights will demand that corporates increase their overall legal spending. This would exponentially expand the country’s share in global legal expenses.  While the growth of the legal industry portrays a promising story for the country, the harsh reality of the associated expenses being borne by the litigants also needs to be addressed.

The Burden of Legal Costs

“Let a lawsuit enter a household and rest assured, even the one who wins shall have lost everything.” is a saying that has held true throughout generations. Today, fighting a case in a court of law is even more expensive than a decade ago. On 25th November National Law Day, the then-president of India Ram Nath Kovid said, “A relatively poor person cannot reach the doors of justice for a fair hearing only because of financial or similar constraints while it’s in our constitutional values and republic ethics. It is a burden on our collective conscience.” The factors behind litigation costs reaching heights are both direct and indirect. The courts are currently facing the mammoth task of clearing up a colossal number of pending cases. The longer previous cases are pending, the more expensive it becomes to pursue new cases. Some of the other factors include legal ignorance, improper framing of charges, lack of laws regulating the fees of professionals and so on. Despite the government initiatives to make legal battles a level-playing field, the ground reality remains that lack of funds significantly affects your ability to contest.

As per a survey by DAKSH, 90% of Indian litigants earn less than 3 lakh per annum and the median cost for this group is around Rs.16,000. As per Prashant Bhushan, a renowned public interest lawyer in the Supreme Court of India, 80% of our country is shut out of the judicial system as they cannot access lawyers in the first place and the quality of legal aid available to them is extremely poor. The Supreme Court is well aware of the problem. In Vinod Seth vs Devinder Bajaj, the apex court had observed: “Under no circumstances, costs should be a deterrent to a citizen with a genuine or bona fide claim, or to any person belonging to the weaker sections whose rights have been affected, from approaching the courts.”

Just 1% of the respondents of the DAKSH survey were utilizing free legal services provided to the weaker sections who otherwise can’t afford to pursue a litigation. It’s not just the access to courts which is limited by financial barriers. Lack of funds is also the main reason why individuals do not meet the conditions for bail. While large conglomerates are building in-house capabilities by hiring veteran lawyers, smaller organizations are building systems and processes that can help them keep the spiralling costs in check. Apart from the exorbitant fees, complicated judicial process also makes it less accessible to ordinary citizens and smaller companies. Not everybody can afford to go through the process because the process is itself a punishing one. For a cash-strapped start-up, it becomes nearly unviable to go against a larger institution given the fact that the course of the litigation itself will drain all their financial resources with zero guarantee of a favourable judgement. The 240th Report of the Law Commission states: “A litigant, who starts the litigation, after some time, being unable to bear the delay and mounting costs, gives up and surrenders to the other side or agrees to settlement which is something akin to creditor who is not able to recover the debt, writing off the debt. This happens when the costs keep mounting and he realises that even if he succeeds, he will not recover the actual costs. Moreover, external recourse funding in the form of loans often come at high interest rates and thus, act as catalysts to the financial nightmare of litigation.

The quest for justice is undoubtedly an expensive one. But is there a way out?

The concept of litigation expenses has been existing for decades now in the western parts of the world. However, it is still at its nascent stage in India. LegalPay offers non-recourse funding to litigants who do have a strong case but lack the financial means to pursue it in order to get a settlement. Litigation funding creates a win-win situation by generating high returns from a cut of that settlement amount for the investors and by allowing the litigant to pursue the case at zero cost and zero risk. Due to the funding being non-recourse in nature, the litigant shall not be required to pay LegalPay anything in case the judgement is not in their favour. Even if the experienced professionals at LegalPay review the case using data-driven analytical tools and decide not to fund it, it would be indicative of the odds being stacked against them. in the case. 90% of applicants who LegalPay did not fund, decided not to pursue the case as it failed the preliminary test of meritocracy, thereby saving significant money which would otherwise have been spent on legal fees.  

Shifting the burden of a litigation to a third-party funder is not just a powerful tool for risk mitigation, but would also play an instrumental role in contributing to the nation’s GDP by allowing growth-oriented businesses to utilize their resources in expanding operations and innovating instead of getting them locked up in a legal case.

For original post visit: https://legal-pay-fund-services.blogspot.com/2022/09/legal-expenses-market-in-india.html

[seedfinance]

10 Top Penny Stocks To Watch After ANY Stock’s 559% Short Squeeze

EVERY stock continues to draw attention to penny stocks

The phenomenon now known as “Short Squeeze Penny Stocks” has taken the retail sector by storm. As the last month of the third quarter began, the focus on these high-risk, high-volatility stocks became evident. When the stocks of companies like Sphere 3D (NASDAQ: ANY) soar over 550% since the beginning of the year, people are sure to notice.

We experienced that in 2021. Right now, EVERY share was trading up to $ 9.49 per share during the morning session on September 2nd. But at the beginning of the year, it was just one more of the penny stocks on the watchlist, which was below $ 2.

Continue reading: The best penny stocks to buy after the BBIG stock breakout? 4 Watch now

A wild mix of headlines related to the crypto industry, speculation, and a surge in interest in ANY as a potential short squeeze stock culminated in an epic breakout this year. If you are an active trader, I don’t have to give you game after game at this point. However, if you are new to this story, here are some of our recent comments on EVERY stock.

Now the “cat is out of the bag”, so to speak. Traders look for data on short interest, float, and other stock structure information to start new trading ideas. We have therefore decided to take a closer look at some companies that are reporting higher short interest and / or lower market prices.

Hot Penny Stocks To Check Out Now

Meta Materials Inc. (NASDAQ: MMAT)

Senseonics Holdings (NYSE: SENS)

Liquid Media Group (NASDAQ: YVR)

Molecular Data Inc. (NASDAQ: MKD)

Data Storage Company (NASDAQ: DTST)

1. Meta Materials Inc. (NASDAQ: MMAT)

Meta Materials stocks have been on fire for the past few weeks. After closing the Torchlight acquisition earlier this year, the focus has been on how the company plans to implement a business plan that was a hot topic even before the merger agreement was formalized. Fast forward and now Meta Materials would like to expand its reach in the green electricity / ESG ecosystem. It also expands its technology offering.

The story goes on

Meta’s most recent acquisition target, Nanotech Security Corp., is in the middle of the company’s next potential roll-up valued at nearly $ 91 million. The deal is designed to advance Meta’s commercialization strategy. In particular, it brings Nanotech’s electron beam lithography equipment, which is expected to significantly reduce production costs. “Nanotech is also adding complementary capabilities that can support META’s markets and accelerating our commercialization plans in vertical areas such as solar, 5G and other antennas, batteries and fuel cells, and carbon capture,” said George Palikaras, President and CEO of META.

The move comes as Meta reported strong profits. This included sales growth of almost 200% in the second quarter. Also, given the huge selling pressure on MMAT stock in recent months, some are viewing it as a potential “short squeeze stock”. We’ll have to see how things play out, but for now it’s still testing the upper levels of the penny stick range.

The best penny stocks to watch on the Meta Materials MMAT stock chart

2. Senseonics Holdings, Inc. (NYSE: SENS)

Another of the penny stocks we’ve talked about a lot over the year is Senseonics. The company specializes in medical diagnostic equipment. In particular, it is developing long-term implantable continuous glucose monitoring systems (CGMs) for diabetics.

No headlines have appeared lately to support the stock’s momentum. However, with traders reporting strong profits at the beginning of this quarter, traders are optimistic about the future of SENS shares. “In the second quarter, we made progress in building awareness of Eversense among patients and providers through a targeted digital direct marketing campaign and presentations of the PROMISE study, an evaluation of our 180-day sensor, at the ADA and ATTD conferences. “Said Tim Goodnow, Ph.D., President and Chief Executive Officer of Senseonics.

Looking ahead, the company submitted the data to the FDA. There is an active review for the company’s Eversense 180-day PMA supplement application. Additionally, Senseonics continues to expect that Senseonics’ global net sales for full year 2021 will be between $ 12.0 million and $ 15.0 million.

In terms of stock structure, this is not one of the “low float penny stocks” to watch out for. However, recent data suggests greater short interest in the stock. Short float information from this article shows it is around 22%.

The Best Penny Stocks To See Senseonics Holdings SENS Stock Chart

3. Liquid Media Group (NASDAQ: YVR)

On the flip side of SENS stock, Liquid Media doesn’t have a massive short float percentage based on the most recent data. However, it shows an outstanding number of shares below 13.6 million. According to most reports, this is viewed as the lower end of the stocks in the audience. Originally known for its media business, YVR stock was added to the NFT category.

Continue reading: Buy hot penny stocks now? 4 watch the market turn bullish

Earlier this year, the company signed a development contract with CurrencyWorks to develop NFTainment.io. The aim was to publish “Red Carpet” NFTs with pre-release versions. But to be honest, recent headlines highlighted the company’s move to strengthen its entertainment and “edutainment” platforms. Last month the company signed a letter of intent to purchase the video content management company Digital Cinema. This week Liquid Media announced a definitive agreement to buy iNDIEFLIX as part of an all-stock deal.

This latest acquisition is expected to close in the “coming days” and button up a deal originally announced in May. “This is an important acquisition for Liquid and our business solution engine as we help independent creative professionals and intellectual property owners monetize their content,” said Ronald Thomson, CEO of Liquid.

With less float, news, and momentum to tailwind, YVR stock could be kept an eye on amid this latest retail trend.

The best penny stocks to watch on the Liquid Media Group YVR stock chart

4. Molecular Data Inc. (NASDAQ: MKD)

We’ve been talking a little more about molecular data lately. This is due to the transition that the company has made from traditional logistics technology to the world of blockchain. It is neither a “low float” nor a “high short” share. However, given the similar industry compared to companies like Sphere 3D, it might be worth considering. As one of the penny stocks on Robinhood under $ 1, volatility was a huge factor. As you’ll see, 2021 was a tough year for the stock in general. However, the recent headlines seem to have sparked additional interest in the market.

Earlier this quarter, the company announced a partnership with Wanxiang Blockchain. The focus is on the digitization of the entire chemical industry. To address things like supply chain bottlenecks, improved e-commerce and the like, the two plan to build a digital platform built on top of the blockchain.

This week, Molecular Data announced a partnership with an investment firm to build blockchain data centers. The company’s press release was vague and didn’t say which US investment firm was. Also, no details were released other than “The partnership will resolve chemical bottlenecks and build blockchain data centers on a commercial scale in America.”

So take what it’s worth Vague headlines were a great source of speculation and increased risk. But given the EVERY stock breakout, some blockchain stocks might find sympathy for the short term.

The best penny stocks to watch the Molecular Data MKD stock chart

5. Data Storage Company (NASDAQ: DTST)

Data Storage Corporation stocks were moving early Thursday morning. That’s partly thanks to the company’s latest headlines. The company announced a managed services model partnership with Precisely. You’re a data integrity software company and the deal aims to bring security software solutions to the data storage cloud.

Data Storage specializes in business services ranging from disaster recovery protection to cloud infrastructure services.

“Adding Precisely advanced solutions in a cloud environment enables us to offer an even more robust and fully functional monthly subscription-based offering that addresses the most common IT security issues, including ransomware,” said Chuck Paolillo, Data Storage CTO. “With a free risk assessment and associated reports, we can pinpoint challenges and resolve any issues we discover immediately.”

In addition to this, DTST stock is also one of the lowest float names on the list of penny stocks. The outstanding stock count on the DTST stock profile page shows that the stock has issued fewer than 7 million. Given that the public float will never be larger than the OS, DTST is in the low float category. The most important thing you need to understand now is that volatility today can play an active role in the development of directional dynamics in the stock market.

Top penny stocks to watch on Data Storage Corporation DTST stock chart

Are penny stocks on your watchlist today?

Whether it’s low-float penny stocks, short squeeze stocks, or momentum trades, these cheap stocks are all the rage right now. It is clear that some are making record returns in a very short period of time. If you are looking for penny stocks to buy right now, understanding the trade is the first line in the sand to cross. Have a plan and strategy before entering a trade. The wins are big, but losses can happen just as quickly.

More Short Squeeze / Low Float Penny Stocks to look at

China Online Education Group (NYSE: COE)

Exela Technologies (NASDAQ: TELL)

Kala Pharmaceuticals (NASDAQ: KALA)

Washington Prime Group Inc. (NYSE: WPG)

Creatd, Inc. (NASDAQ: CRTD)

source https://seedfinance.net/2021/09/02/10-top-penny-stocks-to-watch-after-any-stocks-559-short-squeeze/

[esglatestmarketnews]

ESG Integration in the Biotechnology Sector

The biotechnology industry plays a crucial role in developing products that are both environmentally friendly and economically profitable. By adapting and modifying biological organisms, processes, and systems found in nature, biotechnology contributes to sustainable industrial development. This article explores the impact of ESG considerations in the biotechnology sector, highlighting the environmental benefits, social contributions, and governance practices that shape the industry's trajectory.

Environmental Advancements in Biotechnology

Biotechnology has the potential to revolutionize agriculture and contribute to sustainable food production. By increasing crop yields and designing more efficient crops, biotechnology can manipulate primary energy flows and reduce the use of fossil fuels in agricultural systems. This technology also helps address environmental challenges such as deforestation and soil erosion. Additionally, biotechnology enables resource recovery, recycling, and hazardous waste disposal, offering environmentally beneficial solutions.

The COVID-19 pandemic has further showcased the positive impact of biotechnology on healthcare infrastructure. Through advancements in biotechnology, the pharmaceutical industry has expanded opportunities for drug development and vaccine manufacturing. These developments have improved healthcare infrastructure, enabling better diagnosis, treatment, and reduction of the seroprevalence rate of COVID-19 infections.

Is your business one of participants to the Biotechnology Industry? Contact us for focused consultation around ESG Investing, and help you build sustainable business practices

ESG Trends 

The biotechnology industry is at the forefront of environmental innovations aimed at increasing efficiency and promoting sustainability. Governments, public institutions, and private organizations alike are investing heavily in environmental biotechnology to protect biodiversity and address waste treatment and bioremediation challenges. This sector has witnessed significant advancements in waste treatment and pollutant removal methods, replacing inefficient and costly chemical-based approaches.

Moreover, industrial biotechnology extends beyond biofuel production. It has transformed various industrial processes, ranging from the production of detergents and textiles to vitamins and antibiotics. By conserving natural resources, reducing costs, and accelerating the development of greener products, industrial biotechnology contributes to sustainable practices.

The biotechnology sector also aligns with the United Nations' Sustainable Development Goals (SDGs) to achieve sustainable development solutions. It addresses SDG 1 by offering agricultural biotechnology solutions that help farmers increase their incomes and reduce vulnerability to climate change. In pursuit of SDG 2, biotechnology produces healthier and more productive crops, reducing food waste and extending shelf life. SDG 3 benefits from biotechnology's development of medicines, vaccines, and tools to prevent and contain epidemics and improve global healthcare quality. Biotechnology also supports SDG 6 by purifying water using bacteria and plants, ensuring clean water and sanitation. Additionally, biotechnology innovations contribute to SDG 8 by providing economic opportunities through the development of medicines and agricultural products. SDG 9 is advanced through investments in biotechnology parks, research and development infrastructure, and partnerships with international organizations.

ESG Risks and Challenges 

While biotechnology offers numerous benefits, it also presents risks and challenges. The commercial availability of biotechnology has led to increased exploitation of biological resources for various applications, including food productivity enhancement, disease treatment, and energy generation. However, these applications have been associated with undesirable outcomes such as diminished species biodiversity, agrobiodiversity loss, environmental contamination, and appropriation of biodiversity through intellectual property rights and patents in developing countries.

The use of genetic engineering and antibiotic marker genes in biotechnology can contribute to the problem of antibiotic-resistant bacteria. Genetic modifications in crops have raised concerns about the loss of natural farming practices, altering the very essence and taste of food. To ensure sustainable practices, biotechnology must prioritize natural and ethical farming methods that do not solely rely on agrochemicals and do not exploit humans, animals, and natural flora and fauna.

The Growth of the Biotechnology Market

The global biotechnology market is projected to reach USD 1,023.92 billion by 2021, with a compound annual growth rate (CAGR) of 13.9% from 2022 to 2030. Governments worldwide are supporting this market by modernizing regulatory frameworks, improving approval processes and reimbursement policies, and standardizing clinical trials. Collaborations between government bodies and biotech companies focus on research and development to develop drugs and vaccines for various diseases. 

Key Companies 

    • AstraZeneca

    • Gilead Sciences, Inc.

    • Bristol-Myers Squibb

    • Sanofi

    • Biogen

    • Abbott Laboratories

    • Pfizer, Inc.

    • Amgen, Inc.

    • Novo Nordisk A/S

    • Merck KGaA

    • Johnson & Johnson Services, Inc.

    • Novartis AG

    • F. Hoffmann-La Roche Ltd.

    • Lonza

Key Benefits of the Biotechnology Industry ESG Thematic Report

The Biotechnology Industry ESG Thematic Report offers several key benefits to its readers. It provides a comprehensive understanding of macro-economic factors, policies, regulations, and innovations impacting the biotechnology industry globally. The report delves into infrastructure developments and ESG issues relevant to the industry, allowing businesses to identify risks and opportunities among leading players. Moreover, it offers clear insights into company actions, progress, and impact, empowering investors to make informed decisions.

Browse more ESG Thematic Reports from the Healthcare Sector, published by Astra - ESG Solutions

About Astra – ESG Solutions By Grand View Research

Astra is the Environmental, Social, and Governance (ESG) arm of Grand View Research Inc. - a global market research publishing & management consulting firm.

Astra offers comprehensive ESG thematic assessment & scores across diverse impact & socially responsible investment topics, including both public and private companies along with intuitive dashboards. Our ESG solutions are powered by robust fundamental & alternative information. Astra specializes in consulting services that equip corporates and the investment community with the in-depth ESG research and actionable insight they need to support their bottom lines and their values. We have supported our clients across diverse ESG consulting projects & advisory services, including climate strategies & assessment, ESG benchmarking, stakeholder engagement programs, active ownership, developing ESG investment strategies, ESG data services, build corporate sustainability reports. Astra team includes a pool of industry experts and ESG enthusiasts who possess extensive end-end ESG research and consulting experience at a global level.

Need expert consultation around identifying, analyzing and creating a plan to mitigate ESG risks related to your business? Share your concerns and queries, we can help!

[marketnewzstack-blog]

Global Automatic Sorting System Market Competitive Outlook & Financial Forecast 2020-2025

The most recent Global Automatic Sorting System Market report published by Market.Biz is that it covers the whole globe as well as regional and local aspects of the market in an understandable way.

Highlights in the Automatic Sorting System research report:

It is a total background assessment of the Automatic Sorting System Market, which incorporates an evaluation of the parent chains, Significant changes in market factors which is one of the crucial parts of this report. Market analysis has a different level of segmentation. the report also merges past and current information and projects the size of the futures market from the viewpoint of value and volume of Market.

Competitive Analysis of Global Automatic Sorting System Market:

In Short, this part of the report i.e. Competitive Analysis is the inclusion of Market Coverage and evaluation of recent trends in the industry's development. Market shares and strategies of key players are the main trajectory of analysis in the Automatic Sorting System report. The Rising niches and regional market segments are also included in the assessment of future forecasts. The objective is the assessment of the past, present and future path of the market. 

Get A Sample Pdf of this report before purchasing: https://market.biz/report/global-automatic-sorting-system-market-2017-mr/142335/#requestforsample

Through theoretical analysis and technology-based vision, this report creates detailed research and comprehensive examination of different market sector development. The reports highlight different Automatic Sorting System market forecast along with threats, Vendor selection criteria, market size, Financial investments promotions, and distributions channel. 

The Key Segmentation Analysed in the Global Automatic Sorting System Market 2020 are as follow:

Manufacturers:��ESG Systems, Ludden & Mennekes Entsorgungs-Systeme GmbH, SSI Shredding Systems Inc., ULMA Handing System, Egemin Automation, Equinox Global Services, OptiBag Systems AB - Envac Optibag, Protea Limited, Vulcan Systems, XiangTanJIaRuiDa, Schouten Sorting Equipment BV, K&K Environmental LLC, Sort-Rite International Inc., Valvan Baling Systems NV, Recycle Systems, Compac Sorting Equipment Inc., REDWAVE a division of BT-Wolfgang Binder, Advanced Sorting Machines (ASM) Srl, COTAO, Envirocombustion Systems Limited, Saiki automation system

Types: Pusher sorting system, Carbel Sorting, Line shaft Diverter, Swing Arm Diverter 

Applications: Retail and wholesale DCs, Food & Beverage, Pharmaceutical and cosmetics industries, E-commerce and mail order companies, Mail sorting centres 

The investigation includes operators and constraining elements of the Automatic Sorting System market along with the effects of these elements on the Automatic Sorting System business during the forecast period of upcoming years. However, the Automatic Sorting System research also expresses the assessment of potential viability in the global market. The research mainly visualizes the exceptional expected growth over the forecast years. 

The Four Key Target Audience of the Automatic Sorting System in the Global Market:

1. Producers of product or Potential shareholders.

2. Dealers, traders, brokers, Sellers, Retailers, foreign buyers, and shippers.

3. cooperative and governing bodies.

4. Locations, Subculture, Needs, Attitudes & Opinion, Personality.

In the Regional Analysis the following areas are the key geographic producers of Automatic Sorting System:

Europe (Germany, UK, France, Italy, Russia, Spain, and Benelux)

North America (the United States, Canada, and Mexico)

Latin America (Brazil, Argentina, and Colombia)

Asia Pacific (China, Japan, India)

The Middle East and Africa

Here is the Inquiry link of the report: https://market.biz/report/global-automatic-sorting-system-market-2017-mr/142335/#inquiry

The Equipment sector is growing rapidly where the Automatic Sorting System is playing a crucial role. The statistical analytics of this report helps in understanding the upcoming trends which help in the growth of the market. the data summarized in this analysis of the market provides proper knowledge of future opportunities and many other forecasts. 

Explore Some of Our Dynamic Blog:

Global Global Forward Collision Avoidance Radar Market Industry Market Research Report

Global Global Conduit Pipe Market Industry Market Research Report

Contact us at:

420 Lexington Avenue Suite 300

New York City, NY 10170, United States 

USA/Canada Tel No: +1-857-2390696

[marketresearchtrendsblog]

Automatic Sorting System Market By Product Type (Pusher sorting system, Line shaft Diverter, Swing Arm Diverter, Carbel Sorting) - Forecast 2020-2025

The automatic sorting systems are mainly used in distribution centres for fashion, consumer electronics, multimedia, pharmacy and post for sorting single items or small packs. How Big is The Global Automatic Sorting System Market? The Automatic Sorting System Market is expected to exceed more than US$ xx Billion by 2025 at a CAGR of xx% in the given forecast period. Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-105531 The Automatic Sorting System Market has been segmented as below: By Product Type: Pusher sorting system Line shaft Diverter Swing Arm Diverter Carbel Sorting By Application: Retail and wholesale DCs E-commerce and mail order companies Mail sorting centres Food & Beverage Pharmaceutical and cosmetics industries By Regional Analysis: North America Europe Asia-Pacific Rest of the World The Automatic Sorting System Market is segmented on the lines of its Product type, application and regional. Based on product type it covers Pusher sorting system, Carbel Sorting, Line shaft Diverter and Swing Arm Diverter. Based on application it covers Retail and wholesale DCs, Food & Beverage, Pharmaceutical and cosmetics industries, E-commerce and mail order companies and Mail sorting centres. The Automatic Sorting System Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries. This report provides: 1) An overview of the global market for Automatic Sorting System Market and related technologies. 2) Analyses of global market trends, with data from 2016, estimates for 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2025. 3) Identifications of new market opportunities and targeted promotional plans for Automatic Sorting System Market. 4) Discussion of research and development, and the demand for new products and new applications. 5) Comprehensive company profiles of major players in the industry. Report Scope: The scope of the report includes a detailed study of Automatic Sorting System Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report COTAO, ULMA Handing System, Egemin Automation, Equinox Global Services, K&K Environmental, LLC, Sort-Rite International, Inc, XiangTanJIaRuiDa, Compac Sorting Equipment Inc, Schouten Sorting Equipment BV, REDWAVE a division of BT-Wolfgang Binder, Advanced Sorting Machines (ASM) Srl, SSI Shredding Systems, Inc, Saiki automation system, OptiBag Systems AB - Envac Optibag, Envirocombustion Systems Limited, Protea Limited, Ludden & Mennekes Entsorgungs-Systeme GmbH, ESG Systems, Vulcan Systems, Recycle Systems and Valvan Baling Systems NV. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players. Reasons to Buy this Report: 1) Obtain the most up to date information available on all Automatic Sorting System Market. 2) Identify growth segments and opportunities in the industry. 3) Facilitate decision making on the basis of strong historic and forecast of Automatic Sorting System Market. 4) Assess your competitor’s refining portfolio and its evolution.

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Hina Miyazu

Shibuya Data Count Email: sales@sdki.jp Tel: + 81 3 45720790

[shristisahu]

Strategies for Risk Management and Procurement in the Pharmaceutical Sector

Originally Published on: SpendEdge |Risk Management Strategy and Procurement Recommendations for the Pharma Industry 

Introduction: The pharmaceutical industry orchestrates a symphony of research, development, manufacturing, quality assurance, and regulatory compliance to bring groundbreaking and safe drugs to the market. This intricate process involves rigorous testing, meticulous clinical trials, and unwavering adherence to strict regulations to ensure both the efficacy and safety of pharmaceutical products. In this intricate dance, risk emerges as the shadow lurking at every turn, embodying the potential for unexpected events that could cast a dark cloud over financial goals and operational triumphs. Procurement, a critical juncture, is not immune to these risks. The failure of suppliers, material supply delays, and compromised material quality loom as significant procurement pitfalls.

Unveiling Pharma Procurement Risks:

Supply Chain Disruptions: Among the paramount perils in pharmaceutical procurement is the looming possibility of supply chain interruptions. Natural disasters, political instability, and unforeseen occurrences can cripple the supply of raw materials or finished goods. These disruptions reverberate through critical pharmaceutical manufacturing and delivery, causing delays and shortages. Ensuring traceability throughout the supply chain is crucial, aiding in the detection and resolution of disruptions or errors. Traceability also unveils transportation bottlenecks that contribute to delivery delays.

Pricing Volatility: Supplier pricing emerges as a substantial risk, demanding vigilant consideration during procurement. Amid the quest for the best rates, buyers must grapple with suppliers' varied pricing strategies. Opting for suppliers with stable pricing strategies minimizes the risk of market price fluctuations. Price forecasting offers a crucial shield against pricing volatility, arming buyers with insights into potential fluctuations and enabling preparation for unforeseen changes.

Vendor Selection Challenges: Pharmaceutical companies seek to harness the expertise of Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs). This shift from historical usage entails a comprehensive shortlisting process that extends beyond capacity considerations. Factors such as technical prowess, therapeutic expertise, financial management, quality, and delivery time further complicate the vendor selection process. Crafting the right vendor partnerships presents a significant challenge.

Leveraging SpendEdge Recommendations for Pharma Procurement:

Supply Chain Traceability: Our comprehensive 360-degree supply chain reports empower you with a deep understanding of constraints and supplier commitments. With advanced awareness of potential supply chain disruptions, proactive strategies can be devised. Our risk assessment reports facilitate the detection of fresh opportunities for enhancing supply chain resilience and rebound capabilities. Anticipating and averting supply chain inflation becomes attainable, enabling agile responses. Supplier experience quantification is harnessed to fortify supply chain resilience.

Vendor Verification: Our robust methodology identifies top suppliers and CMOs by evaluating historical data, performance, quality, and financial stability. Rigorous vendor onboarding and regular data verification protect against supplier malpractices such as drug counterfeiting and financial fraud. Early warnings about financial risks and operational issues enable proactive savings. ESG-aligned supplier practices are scrutinized, offering insights into reliable sources.

Price Forecasting and Analysis: Category pricing intelligence uncovers market price trends, equipping you to act before price fluctuations occur. Price policy analyses of potential suppliers guide the quest for the best supplier rates. Detailed cost breakdown analysis sheds light on cost drivers and market trends, unveiling areas of procurement overspending. Enhanced cost management aligns with agile procurement strategies.

Success Stories: Transforming Pharma Procurement with SpendEdge Support Amid the labyrinth of risk management, organizations strive to tame uncertainty through sound strategies. The pharmaceutical realm grapples with procurement risks, encompassing supplier fraud, supply chain uncertainties, and price volatility. Within this landscape, risk management stands tall.

A US-based pharmaceutical giant sought SpendEdge's expertise to unravel the complexity within their procurement landscape. Delays and subpar material deliveries triggered by insufficient supplier analysis impelled them to seek our aid. Moreover, monitoring pricing changes and responding swiftly presented challenges. Our insights delved into supply chain functioning, pinpointing disruptions causing procurement delays. Rigorous risk assessment evaluated supplier performance, pricing strategies, and delivery schedules. Price forecasting illuminated market pricing shifts.

The company embraced the transformative power of our insights, ensuring timely deliveries, preempting price fluctuations, and eradicating supply chain disruptions.

Connect with SpendEdge Now: For akin challenges that call for transformative solutions, tap into our expertise.

Contact us today to chart a course towards procurement excellence, fortified resilience, and triumphant success.

[priyanka16me]

Geophysical Services Market Estimated to Record Highest CAGR by 2026

The global well intervention market was valued at nearly US$ 6 Bn in 2017 and is anticipated to expand at a CAGR of more than 6% from 2018 to 2026, according to a new report titled ‘Well Intervention Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 –2026’ by Transparency Market Research (TMR) . Rapid depletion of oil reserves is influencing the outlook of the global oil and gas industry. Hence, efforts are being undertaken to explore new oilfield reserves, particularly in North Sea, South China Sea, Gulf of Mexico, and the Persian Gulf, in order to cater to this ever increasing demand. This, in turn, is anticipated to offer substantial expansion opportunities to the well intervention market in the near future.

Rise in Investments in Offshore Oil & Gas to Boost Demand and Weakening Prices of Crude Oil to Impact Market Expansion

Excess depletion of onshore oil and gas assets has shifted the investments from onshore to offshore oil and gas assets. Rise in demand for energy and increasing expenditure in the shallow, deep, and ultra-deep water oil & gas assets are expected to propel demand for well intervention services. Several key players in the oil and gas industry are investing heavily in offshore assets. Thus, a move from onshore to deep-water offshore drilling is expected to gain momentum, led by major international oil and exploration & production companies that stand to uncover large discoveries and are willing to pour substantial dollars into exploration efforts. More than 70% of new discoveries have been found in offshore areas.

Declining prices of crude oil could have an adverse effect on well intervention services across the globe. Governments of several nations have imposed strict norms and guidelines related to carbon emissions, which has led to a shift in investments into the renewable energy sector. Governments of several countries are providing subsidies related to generation of renewable-based power, boosting the renewable energy sector.

Coiled Tubing Services to Remain a Dominant Segment over the Forecast Period

Coiled tubing services consist of reliable and efficient well intervention for vertical, horizontal, highly deviated, and live wells. Coiled tubing is designed to improve well and reservoir performance. Its applications include wellbore cleanout, matrix and fracture stimulation, logging, nitrogen kickoff, perforation, sand control, drilling, well circulation, mechanical isolation, and cementing. Coiled tubing and slickline are widely used during well intervention. Coiled tubing is an important type of service, as it can be used for vertical, horizontal, highly deviated, and live wells.

Light Well Intervention Segment Dominates the Global Well Intervention Market and is Expected to Expand Further

In terms of type, the light well segment dominated the global well intervention market with more than 50% share in 2017. It was closely followed by the medium wells segment. More than 6,000 subsea wells existed across the globe in 2016. Increase in oil recovery from the wells is augmenting the subsea light well intervention services. These services include repair, installation, and manipulation of mechanical devices (plugs, valves, screens, etc.), scale removal, perforations and re-perforations, fluid sampling, zone isolation, well abandonment, and chemical treatment. Light well intervention technology lowers the intervention cost by about one-third i.e., intervention cost is about 50% to 60% less than that of the drilling rig. This enables more intervention work, which results in better exploration of subsea wells. Light well intervention is a cost-effective alternative for well intervention and repair of subsea wells compared to drilling rigs.

Countries in North America, especially U.S. to Lead Well Intervention Market

North America dominated the global well intervention market in 2017 and the trend is expected to continue over the forecast period. The U.S. has drilled more than 14,000 wells in 2016 and is expected to explore more oil and gas wells in the near future. The U.S. upstream market is a complex combination of technical, financial, political, and logistical factors. Increase in exploitation of unconventional reserves is likely to boost demand for well intervention in the near future. Among unconventional plays, the Permian basin will certainly lead to U.S. supply growth.

Highly Competitive Market with Domination of Top Players

The global well intervention market is a highly competitive. Leading players dominate the market. It is highly fragmented with a large number of local and international players competing in the market. Leading players dominate the market. Key players operating in the well intervention market are Schlumberger Limited, HELIX ESG, GE, Halliburton, Oceaneering International, Inc., Expro Group, Hunting Energy Services, National Oilwell Varco, Deepwell AS, and Weatherford International Plc.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

[marketnewsandtrends-blog]

Global Material Testing Equipment Market Insights and Forecast 2021

13-feb-2019 Global Material Testing Equipment Market is segmented on the basis of type as Twin column, Load system, Single column, High elongation and others. A device that is employed to examine various physical characteristics of the materials ranging from bending, torsion, weariness, hardness, creep, robustness, rigidity and density is known as a material testing equipment. The device usually detects the properties of the material before it is actually employed to produce variety of products. The most striking aspects that are associated with the use of these devices may include augmented speed, huge analysis capability, and enhanced precision. With gradual rise in the concerns for safety, the role of the material testing equipment has increased to material evaluation, research & development, quality assurance, and modern product introduction. With the help of these equipments, the daily safety and quality of life of the customers has been improved. It has been noticed that the market is currently undergoing a significant trend of rising prerequisite for automated testing machines. The factors that are playing a significant role in boosting the market growth entails implementation of strict regulations and norms by the government authorities concerning the employment of various materials, mounting demands across automotive, aerospace, and primary metal industries, rising applications and prerequisites, rise in the industrialization, technological developments, rise in the investments by the leading manufacturers, and constant innovations in the fields of composites, nanotechnology, and biomedical. The only factor that is hampering the market growth may include rising prerequisite for augmented investments. It has been anticipated that the Material Testing Equipment Market will experience a robust growth in the next couple of years due to growing scope and applications across various sectors. Material Testing Equipment Market is segmented on the basis of capacity as Puncture Strength, Tear Resistance, Tensile Strength, Coefficient of Friction, Compression, and Flexure/Bend Strength. Material Testing Equipment Market is segmented on the basis of application as Automotive, Medical, Wood, Aerospace, Metal industries, Packaging, Textiles, Electronics, Pharmaceutical, and Paper and Board. Material Testing Equipment Market is segmented on the basis of geography as North America, Southeast Asia, China, Europe, Japan, and India. Among all the geographical regions, North America has come up as the leader of the market and it is simultaneously taking up the largest share in the market, the reason being technological advancements, robust growth of industrial sectors, augmented awareness among the end users, and rise in the industrialization. In contrast, Europe and Asia Pacific are also exhibiting a steady growth in the market due to emergence of huge market growth opportunities in these regions. The key players operating in the Material Testing Equipment Market are recognized as Illinois Tool Works, Applied Test Systems, UTEST Material Test Equipment, Fine Group, Shimadzu, Tinius Olsen, Bose ESG, MTS System, and Zwick Roell. This report studies Material Testing Equipment in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering • Applied Test Systems • ElectroForce Systems • Illinois Tool Works • MTS Systems • Zwick Roell • Fine Group • LABQUIP • Shimadzu • Tinius Olsen • UTEST Material Test Equipment • Wirsam Scientific By types, the market can be split into • Type I • Type II • Type III Request a Sample Copy of This Report: https://www.radiantinsights.com/research/global-material-testing-equipment-market-professional-survey-report-2016/request-sample By Application, the market can be split into • Application 1 • Application 2 • Application 3 By Regions, this report covers (we can add the regions/countries as you want) • North America • China • Europe • Southeast Asia • Japan • India If you have any special requirements, please let us know and we will offer you the report as you want.

[ethicsustinvest]

PODCAST: Sustainable Pandemic Portfolios

Sustainable pandemic portfolios exhibit many options. They include companies in industries such as renewable energy, infrastructure, pharmaceuticals, biotech, information technology, etc. Read this post for ideas. Also, discover the companies that have failed to disclose climate data. Do you invest in them? Plus, an ETF that invests in companies promoting minority empowerment. And much more

PODCAST: Sustainable Pandemic Portfolios

Transcript & Links, Episode 34, June 19, 2020

Hello, Ron Robins here. Welcome to podcast episode 34 published on June 19 titled “Sustainable Pandemic Portfolios”— and presented by Investing for the Soul. investingforthesoul.com is your site for vital global ethical and sustainable investing news, commentary, information, and resources.

Remember that you can find a full transcript, links to content – including stock symbols and bonus material – at this episode’s podcast page located at investingforthesoul.com/podcasts.

And Google any terms that are unfamiliar to you.

-------------------------------------------------------------

1) Sustainable Pandemic Portfolios

Zacks is one of our favourite research groups in these podcasts. Recently viewed on Yahoo! Finance is a new article by them titled ESG Investing Trend to Stay Strong Post Pandemic: 5 Top Picks. Here are the five, quoting first their names, and then Zacks comments on each one. Incidentally, a Zacks Rank #1 is a strong buy and a 2 rank is a buy.

Quote, “1. Eli Lilly and Company (LLY) discovers, develops, manufactures, and markets pharmaceutical products. The company’s expected earnings growth rate for the current year is 12.8% compared with the Zacks Large Cap Pharmaceuticals industry’s projected earnings growth of 7.9%... Eli Lilly and Company flaunts a Zacks Rank #1.

2. AbbVie Inc. (ABBV) discovers, develops, manufactures, and sells pharmaceuticals. The company’s expected earnings growth rate for the current year is 19.8% compared with the Zacks Large Cap Pharmaceuticals industry’s projected earnings growth of 7.9%... AbbVie sports a Zacks Rank #1.

3. NVIDIA Corporation (NVDA) operates as a visual computing company. The company’s expected earnings growth rate for the current year is 36.4% against the Zacks Semiconductor - General industry’s projected earnings decline of 14.3%... NVIDIA holds a Zacks Rank #2.

4. Fortinet, Inc. (FTNT) provides security solutions [in] all parts of IT infrastructure. The company has an expected earnings growth rate of 12.6% for the current year against the Zacks Security industry’s estimated decline of 15.3%... Fortinet carries a Zacks Rank #2.

5. Bristol-Myers Squibb Company (BMY) discovers, develops, and sells biopharmaceutical products world. The company’s expected earnings growth rate for the current year is 30.9% compared with the Zacks Large Cap Pharmaceuticals industry’s projected earnings growth of 7.9%... Bristol-Myers Squibb holds a Zacks Rank #2.” End quotes.

-------------------------------------------------------------

2) Sustainable Pandemic Portfolios

Also from Zacks, Nitish Marwah has written a piece titled Make Beaucoup Money With These 4 Socially Responsible Funds, I found it on Nasdaq.com. (Bow Koo). Again, I’ll mention the fund followed by brief quotes on that fund from the article.

Quote, “1. New Alternatives Fund Class A (NALFX) invests in companies that contribute to a sustainable environment. The fund seeks long-term capital growth with income as its secondary objective… New Alternatives Fund Class A has a Zacks Mutual Fund Rank #1 and an annual expense ratio of 1.08%.

2. Fidelity Select Environment and Alternative Energy Portfolio (FSLEX). The fund invests the majority of its assets in securities of companies that provide business services related to alternative and renewable energy, energy efficiency, pollution control, water infrastructure, waste and recycling technologies or other environmental support etc.… Fidelity Select Environment and Alternative Energy Portfolio has a Zacks Mutual Fund Rank #2 and an annual expense ratio of 0.85%.

3. Parnassus Core Equity Fund - Investor Shares (PRBLX) [It] invests in large-cap companies which have long-term competitive advantage and positive performance on ESG criteria… Parnassus Core Equity Fund - Investor Shares has an annual expense ratio of 0.86%.

4. Parnassus Mid Cap Growth Fund - Investor (PARNX) seeks appreciation of capital by investing the lion’s share of its assets in mid-sized growth companies. The Parnassus Mid Cap Growth Fund - Investor has an annual expense ratio of 0.84%.” End quotes.

-------------------------------------------------------------

3) Sustainable Pandemic Portfolios

Continuing with a big theme in this podcast is that of renewable energy. A post titled 6 Alternative Energy Stocks Still Have Significant Upside Potential and written by someone new to these podcasts, Jon C. Ogg. It appeared on the 24/7wallstreet.com site. Following the same procedure, I’ll first mention the company and then quotes related to that company from the article.

Solar Related

2. Enphase Energy (NASDAQ: ENPH) Shares of Enphase Energy Inc. saw a sixfold rise from the start of 2019 into late summer, and after pulling back it ran even higher up to $70 or so… Enphase… offers semiconductor-based microinverters for solar panels AC battery storage systems… earnings growth is expected to be almost 40% from 2020 to 2021.

5. Vivint Solar Inc. (NYSE: VSLR) offers distributed solar energy to residential customers by owning and installing solar energy systems in long-term contracts… The company recently closed on $545 million in new financing from two combined packages, and its revenues are expected to grow in 2020 and in 2021. It is expected to reach profitability again in the next two years.

Other

“1. Bloom Energy (NYSE: BE) After coming public in late 2018 just in time to catch the market crater in the fourth quarter of that year, Bloom Energy Corp. has struggled… A clean stationary platform of solid oxide fuel cell technology for reliable and uninterruptible power is the driving force. Bloom Energy cannot only blame circumstances for its lack of enthusiasm, but this was always considered one of the future cleantech leaders prior to its initial public offering.

3. Green Plains (NASDAQ: GPRE) is one of the independent leaders in ethanol. It also has been using the alcohol to make hand sanitizers… Again, this is not the primary thought that might come to mind in alternative or renewable energy with other aspects of its business, but it has a primary role when it comes to ethanol.

4. Plug Power (NASDAQ: PLUG) Despite a weaker overall market, Plug Power Inc. stock managed to rise during the first half of the week of June 12. The maker of hydrogen fuel cell systems that replace conventional batteries saw some rekindled interest after it was started as Overweight and assigned a $7 price target at Barclays.

6. Capstone Turbine (NASDAQ: CPST) [This one] is extremely speculative. Capstone Turbine Corp. develops and sells microturbine technology solutions for stationary distributed power generation. With a mere $25 million market capitalization, there have been no recognizable analyst calls in quite some time here… Capstone has been a chronic disappointment in its 20-year history as a stock. Again, this one is speculative even for the speculative sector.” End quotes.

-------------------------------------------------------------

4) Sustainable Pandemic Portfolios

Now, this is important for all ethical and sustainable investors. The article is titled Top investors publish list of companies that have failed to disclose climate data and appear on the Business Green site. It’s written by James Murray. So why do companies not disclose such data? Do they have something to hide? To see the list go to this page.

-------------------------------------------------------------

5) Sustainable Pandemic Portfolios

Another new analyst to these podcasts is Reuben Gregg Brewer. He’s written a piece with the title 3 Infrastructure Stocks to Buy Right Now. These stocks are often mentioned in these podcasts.

Quoting Mr. Brewer, “Companies that own infrastructure often pay generous dividends from the reliable cash flows their assets generate. If that sounds like something you'd like to have in your portfolio, then you should take a close look at diversified Brookfield Infrastructure Partners (NYSE: BIP), midstream-focused Enterprise Products Partners (NYSE: EPD), and utility NextEra Energy (NYSE: NEE) right now.” End quote.

-------------------------------------------------------------

6) Sustainable Pandemic Portfolios

Our friend Tim Nash over at Corporate Knights has another insightful post titled Pandemic Portfolio: Spotlight on the NAACP Minority Empowerment ETF.

He writes that,

“Protests have erupted across the world calling for racial equality and police reform. Although these protests have had little impact on the market, they’ve raised a good question: can investors support companies that promote minority empowerment while earning market-rate financial returns?

The NAACP Minority Empowerment ETF (NACP) is an exchange-traded fund (ETF) from Dallas-based Impact Shares, which specializes in socially conscious ETFs. According to its fact sheet, the NAACP ETF ‘is designed to provide exposure to U.S. companies with strong racial- and ethnic-diversity policies in place, empowering employees irrespective of their race or nationality.’

… Since its inception in July 2018, the NAACP Minority Empowerment ETF has closely tracked and actually outperformed the S&P 500 by about 4%... [though with] only about US$4 million in assets under management, liquidity issues could arise… the fund has a high management-expense ratio (MER) of 0.75%... “ End quotes.

Lastly, Mr. Nash says, “I’m happy there’s an option for investors to support companies that are leading on diversity policies and minority empowerment.” End quote.

-------------------------------------------------------------

End Comment

Well, these are my top news stories and tips for this podcast: Sustainable Pandemic Portfolios.

And to get all the links, stock symbols, and more, or to read the transcript of this podcast and with additional information too, please go to investingforthesoul.com/podcasts and scroll down to this episode.

Also, be sure to click the like and subscribe buttons in iTunes/Apple Podcasts or wherever you download or listen to this podcast.

And please click the share buttons to share this podcast with your friends and family. That way you can help promote not only this podcast but ethical and sustainable investing globally. We can all do our part in helping create a better world – especially in these deeply troubled times.

Contact me if you have any questions.

Stay well, healthy, and wise!

Thank you for listening.

Talk to you again on July 3. Bye for now.

© 2020 Ron Robins, Investing for the Soul.

Click here to download the episode

[ethicsustinvest]

PODCAST: ESG Bonds and Bond Funds, Stock Alpha, More…

ESG bonds and bond funds gaining investors. Municipal and non-profit bonds for ethical and sustainable investors. Analyst likes 25 sustainable stocks that make you feel good while making you money. ESG stocks beating S&P by 45% this year! Plant-based meat alternative food products gaining big in popularity with important knock-on effects for food stocks. More…

PODCAST: ESG Bonds and Bond Funds, Stock Alpha, More…

Transcript & Links, Episode 19, November 22, 2019

Hello, Ron Robins here. Welcome to podcast episode 19 titled ESG Bonds and Bond Funds, Stock Alpha, and More… for November 22, 2019—presented by Investing for the Soul. investingforthesoul.com is your site for vital global ethical and sustainable investing news, commentary, information, and resources.

And, Google any terms that are unfamiliar to you.

Also, you can find a full transcript, live links to content, and often bonus material to these podcasts at their episodes’ podcast page located at investingforthesoul.com/podcasts.

Now to this podcast!

-------------------------------------------------------------

ESG Bonds and Bond Funds (1)

Usually, when we think of ethical and sustainable investing we almost always think about stocks. But for most investors who prioritize personal values in investing, ESG bonds should also be a significant part of one’s portfolio. So now let’s get a little more into that.

Incidentally, later in this podcast, I’ll talk more about some new ESG stock recommendations and about ESG stock alpha! That is, how terrifically well ESG stocks are doing!

One interesting but overlooked debt asset class for ethical and sustainable investing, particularly in the US, are non-profit municipal ESG bonds. Karen Hube in an illuminating article titled, Future Returns: ESG Investing in Nonprofit Municipal Debt provides insight into this. The article appeared in Barron’s PENTA pages.

In her article, Ms. Hube quotes Buck Stevenson, managing director, and portfolio manager at Silvercrest Asset Management Group in New York. She quotes him as saying that “Municipal bonds issued by small nonprofit groups working to bring about change in their communities can satisfy investors’ growing appetite for impact investing ideas while paying yields ranging from 4.5% to 6%...

Community hospitals, charter schools, and organizations providing mental health care and veterans services are among the groups that are typically structured as nonprofit organizations with 501c(3) status, and can issue debt to raise funds for improvements, new facilities, equipment, and other needs.” End quote

And interest received by investors in this type of debt in the US is often exempt from personal taxes. So, real after-tax yields can sometimes be pretty good!

-------------------------------------------------------------

ESG Bonds and Bond Funds (2)

Another article on ESG bonds and bond funds is titled How Advisors Use ESG Bond ETFs by Lara Crigger on the ETF.com site. Ms. Crigger interviews several ESG analysts and portfolio managers to get their picks on ETFs comprised of ESG bonds.

She first quotes Johann Klaassen, EVP & CIO of Horizons Sustainable Financial Services. Mr. Klaassen likes the VanEck Vectors Green Bond ETF (GRNB), the Nuveen ESG U.S. Aggregate Bond ETF (NUBD), the Sage ESG Intermediate Credit ETF (GUDB), and the Invesco Taxable Municipal Bond ETF (BAB).

Another interviewee, Maya Philipson, Principal of Robasciotti & Philipson recommends the PIMCO Intermediate Municipal Bond Active ETF (MUNI).

Then, Scott Arnold, Partner & Portfolio Manager at IMPACTfolio talks about how he also likes the Nuveen ESG U.S. Aggregate Bond ETF (NUBD). And on a more riskier level, Mr. Arnold likes the new Nuveen ESG High Yield Corporate Bond ETF (NUHY).

-------------------------------------------------------------

ESG Bonds and Bond Funds (3)

Regarding riskier ESG bonds and bond funds, ETFtrends.com ran an article titled High Yield is Making Its Way into ESG Investing by Ben Hernandez. He writes “The search for yield is certainly a global phenomenon given the low rates offered in government debt around the world. It opens the doors for ESG funds to shine by offering high yield bond options as in the case of BlackRock’s iShares € High Yield Corp Bond ESG UCITS ETF (EHYD) and the iShares $ High Yield Corp Bond ESG UCITS ETF (DHYD).” End quote.

The article also has the following quote, “’As evidence increasingly shows that sustainability-related factors can help investors build more resilient portfolios, we are moving into an era where sustainable investing will be the standard way to invest,’ said Meaghan Muldoon, head of sustainable investing EMEA at BlackRock.” End quote.

It should be noted that applying ESG and sustainability criteria to high yield bonds does have a chance to improve the quality and performance of a high yield debt in a portfolio.

However, generally, high yield ESG bonds are still riskier than better-rated bonds.

-------------------------------------------------------------

ESG Bonds and Bond Funds (4)

For a deeper inside look into ESG bonds and bond funds of the high yield variety, I refer you to this article, Looking under the hood of an ESG-focused high-yield bond fund. It’s by Jeff Benjamin at InvestmentNews. Mr. Benjamin interviews Tim Leary, lead manager of the RBC BlueBay High Yield Bond Fund (RGHYX). The fund’s portfolio consists of high yield ESG bonds.

Mr. Leary commenting on his fund says that “The $54 million fund, which was launched in 2012, has an expense ratio of 58 basis points and a five-star rating from Morningstar. It has gained 13.7% from the start of the year, beating both the benchmark and the category average.” End quote

Additionally, he does have this warning about his and other high yield funds – euphemistically often called ‘junk bond’ funds. Quote, “The leveraged finance markets and high-yield markets in general are a risky place to invest because they tend to be more opaque.” End quote.

Furthermore, Mr. Leary says about his fund that “From a sector standpoint, we tend to be overweight financials, as well as financial services companies, cable and media names. Both from an ESG perspective but also from an overall view, we are materially underweight energy, metals and mining, and utilities.” End quote.

Incidentally, you should know that there’s a big debate about greenwashing when it comes to ESG bonds and bond funds, most especially of the high yield variety. So, talk to your advisor before investing in them.

-------------------------------------------------------------

Stock Alpha (1)

Turning our attention back to ESG stock alpha, John Csiszar outlines 25 Investments That Make You Feel Good While You Make Money. His article was reposted on Yahoo! Finance from GOBankingRates.

Most of his picks are typical of what you might find in most ESG stock indexes and funds. His picks are, in alphabetical order:

3M (MMM); Aflac (AFL); Avnet (AVT); Best Buy (BBY); Colgate-Palmolive (CL); Kimberly-Clark (KMB); Microsoft (MSFT); PepsiCo (PEP); Royal Caribbean Cruises (RCL); Salesforce.com (CRM); US Bancorp (USB); Voya Financial (VOYA); Weyerhaeuser (WY); Wyndham Hotels & Resorts (WH); Hilton (HLT); Beyond Meat (BYND); Vanda Pharmaceuticals (VNDA); Tesla (TSLA); Ecolab (ECL)’ Starbucks (SBUX); Fluor (FLR); Texas Instruments (TXN); UPS (UPS); International Paper (IP); Intel (INTC)

-------------------------------------------------------------

Stock Alpha (2)

The following two articles talk about how our trend towards vegetarianism and veganism are having on food industry trends and food-related stocks.

The first article is Americans, especially millennials and Gen Z, are embracing plant-based meat products by Sheril Kirshenbaum and Douglas Buhler on the GreenBiz site. These researchers find that “With debate over the impacts of meat production intensifying, we have been tracking U.S. attitudes related to plant-based alternatives through Michigan State University’s Food Literacy and Engagement Poll. The results reveal a growing appetite for plant-based meat among consumers, especially millennials and Generation Z…

Our survey found that during the previous 12 months, 35 percent of respondents had consumed plant-based meat alternatives. Of that group, 90 percent said they would do so again. Among those who had not yet eaten plant-based meat alternatives, 42 percent were willing to try them, while 30 percent of that group remained unwilling.

We also identified very significant generational differences in attitudes. Nearly half (48 percent) of respondents under 40 were already eating plant-based meats, while just 27 percent of those aged 40 and over had tried these products.” End quote.

The second post comes from Interactive Investor with the title Why this $5bn stock is not just for vegans by Rodney Hobson. Mr. Hobson focuses on the extraordinary stock alpha of Beyond Meat’s stock price. It soared from its IPO price of $25 to about 10 times that and is now back to around $80. His comment, “There is no shortage of rivals making vegan alternatives to meat and competition is likely to intensify. However, those companies with a solid base and proven track record are ahead of the game. Beyond Meat has been going for 10 years now.” End quote.

-------------------------------------------------------------

Stock Alpha (3)

And finally, here’s a story to cheer every ethical and sustainable investor! It’s by Brendan Coffey – who I’ve previously quoted talking about the remarkable stock alpha that ESG stocks are having this year. Writing for Forbes.com, his post is titled, ESG Stocks Are Beating The S&P By 45% This Year.

Yup, he says that “ESG funds are raking in the dough in 2019, pulling in $13.5 billion in new investor money in the first three quarters of the year, according to a recent report by Morningstar. But how is the ‘typical’ ESG portfolio doing? It’s handily besting the S&P 500, returning more than 32% to the S&P’s 22%, through October. That’s a 45% outperformance.” End quote.

So, as one famous stock market commentator says, ‘stay with the drill!’

-------------------------------------------------------------

Well, these are my top news stories and tips for ethical and sustainable investors over the past two weeks.

Again, to get all the links or to read the transcript of this podcast and sometimes get additional information too, please go to investingforthesoul.com/podcasts and scroll down to this episode.

And be sure to click the like and subscribe buttons in iTunes/Apple Podcasts or wherever you download or listen to this podcast and please click the share buttons to share this podcast with your friends and family. That way you can help promote not only this podcast but ethical and sustainable investing globally and help create a better world for us all.

Please don’t hesitate to contact me if you have any questions about the content of this podcast or anything else related.

A big thank you for listening.

Come again! And my next podcast is scheduled for December 6. See you then. Bye for now.

© 2019 Ron Robins, Investing for the Soul.

Click here to download the episode

[marketnewsandtrends-blog]

Global Material Testing Equipment Market Segment Forecasts Up to 2021, Research Reports:Radiant Insights, Inc

20-nov-2018 Global Material Testing Equipment Market is segmented on the basis of type as Twin column, Load system, Single column, High elongation and others. A device that is employed to examine various physical characteristics of the materials ranging from bending, torsion, weariness, hardness, creep, robustness, rigidity and density is known as a material testing equipment. The device usually detects the properties of the material before it is actually employed to produce variety of products. The most striking aspects that are associated with the use of these devices may include augmented speed, huge analysis capability, and enhanced precision. With gradual rise in the concerns for safety, the role of the material testing equipment has increased to material evaluation, research & development, quality assurance, and modern product introduction. With the help of these equipments, the daily safety and quality of life of the customers has been improved. It has been noticed that the market is currently undergoing a significant trend of rising prerequisite for automated testing machines. Request a Sample Copy of This Report: https://www.radiantinsights.com/research/global-material-testing-equipment-market-professional-survey-report-2016/request-sample The factors that are playing a significant role in boosting the market growth entails implementation of strict regulations and norms by the government authorities concerning the employment of various materials, mounting demands across automotive, aerospace, and primary metal industries, rising applications and prerequisites, rise in the industrialization, technological developments, rise in the investments by the leading manufacturers, and constant innovations in the fields of composites, nanotechnology, and biomedical. The only factor that is hampering the market growth may include rising prerequisite for augmented investments. It has been anticipated that the Material Testing Equipment Market will experience a robust growth in the next couple of years due to growing scope and applications across various sectors. Material Testing Equipment Market is segmented on the basis of capacity as Puncture Strength, Tear Resistance, Tensile Strength, Coefficient of Friction, Compression, and Flexure/Bend Strength. Material Testing Equipment Market is segmented on the basis of application as Automotive, Medical, Wood, Aerospace, Metal industries, Packaging, Textiles, Electronics, Pharmaceutical, and Paper and Board. Material Testing Equipment Market is segmented on the basis of geography as North America, Southeast Asia, China, Europe, Japan, and India. Among all the geographical regions, North America has come up as the leader of the market and it is simultaneously taking up the largest share in the market, the reason being technological advancements, robust growth of industrial sectors, augmented awareness among the end users, and rise in the industrialization. In contrast, Europe and Asia Pacific are also exhibiting a steady growth in the market due to emergence of huge market growth opportunities in these regions. The key players operating in the Material Testing Equipment Market are recognized as Illinois Tool Works, Applied Test Systems, UTEST Material Test Equipment, Fine Group, Shimadzu, Tinius Olsen, Bose ESG, MTS System, and Zwick Roell. This report studies Material Testing Equipment in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering • Applied Test Systems • ElectroForce Systems • Illinois Tool Works • MTS Systems • Zwick Roell • Fine Group • LABQUIP • Shimadzu • Tinius Olsen • UTEST Material Test Equipment • Wirsam Scientific By types, the market can be split into • Type I • Type II • Type III Browse Full Research Report With TOC: https://www.radiantinsights.com/research/global-material-testing-equipment-market-professional-survey-report-2016 By Application, the market can be split into • Application 1 • Application 2 • Application 3 By Regions, this report covers (we can add the regions/countries as you want) • North America • China • Europe • Southeast Asia • Japan • India If you have any special requirements, please let us know and we will offer you the report as you want.